Bioretec Oy

€0.02As of Sun 8 Nov 2026, 12:00 UTC

HEL:BRETECHealthcare

Country Finland

PE (Fwd) —

TSR 5Y CAGR (61.50%)

Div yield —

ROE (97.26%)

Medical Devices

Beta (5Y) —

PE TTM —

TSR TTM (97.59%)

Mkt cap €30.59M

ROIC (110.74%)

SE Grade™

—

Value

—

Quality

Moat

1Y Price

Reference

€0.0236

—

3.46%

—

Strong Sell 0|0|0|0|1

TTM

FYE 31 Dec EUR

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

3.522

Revenue€M

—

2.942

3.906

4.544

3.522

3.771

6.18%

—

(22.49)

Revenue growth%

—

32.78

16.32

(22.49)

7.09

16.32

—

65.72

Gross margin%

—

72.58

69.84

70.89

65.72

65.54

70.36

—

(246.64)

Operating margin%

—

(77.90)

(77.67)

(92.48)

(246.64)

(100.00)

(85.19)

—

(269.27)

Net margin%

—

(82.13)

(96.99)

(101.54)

(269.27)

(100.00)

(99.27)

—

P/E ratio (avg)x

—

EV/EBITx

—

(135.99)

FCF yield (avg)%

—

(0.62)

(0.58)

(0.82)

(2.52)

—

(0.72)

—

(293.78)

FCF margin%

—

(89.06)

(92.13)

(128.43)

(293.78)

(100.00)

(110.28)

—

1.091

FCF / Net incomex

—

1.084

0.950

1.265

1.091

—

1.088

—

(110.74)

ROIC%

—

(94.44)

(76.62)

(69.65)

(110.74)

(41.38)

(85.53)

—

(97.26)

Return on equity%

—

(125.78)

(74.65)

(51.35)

(97.26)

(47.89)

(85.95)

—

(81.20)

Return on assets%

—

(69.28)

(35.55)

(40.21)

(81.20)

(35.59)

(54.74)

—

(0.03)

EPS€

—

(0.01)

(0.02)

(0.03)

(0.01)

—

(75.67)

EPS growth%

—

(38.38)

(7.95)

(75.67)

60.23

(38.38)

—

0.03

Bookvalue per sh€

—

0.01

0.03

0.02

50.34%

—

(0.03)

FCF per share€

—

(0.01)

(0.02)

(0.03)

(0.01)

—

Dividend per sh€

—

Div yield (avg)%

—

Payout ratio%

—

333.7

Shares (diluted)M

—

223.1

252.8

285.2

333.7

◌333.7

14.36%

—

(17.00)

Buyback yield%

—

(13.31)

(12.80)

(17.00)

◌—

(13.31)

—

0.044

D/E ratiox

—

0.371

0.127

0.069

0.044

0.521

0.098

—

6.960

Enterprise value€M

—

425.1

620.6

710.4

409.5

10.73

(1.23%)

—

0.138

LT debt€M

—

0.703

0.671

0.434

0.138

2.827

(41.85%)

—

Peers (US$31.94M)

Cap (US$)

Nexstim Plc

79.89M

1,706x

Modulight Oyj

51.52M

—

Biohit Oyj

37.22M

10.95x

Nortech Systems…

31.96M

31.90x

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

(6.636)

(6.879)

Own earn%

—

Sh yield%

(17.00)

(13.31)

Owners

Insiders/Inst%

—

8.01

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

0/4

Revenue growth years

2/3

EPS growth years

0/3

Dividend streakyrs

Op margin range%

−247–−78

$1 testx

—

Incr. ROIC%

—

Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide.

Growth vs revenue

Latest

Trend

3Y CAGR

Rel growth

Revenue

€3.522M

6.18%

1.00×

Cost of revenue

€1.207M

14.39%

1.25×

Operating expenses

€11.00M

35.45%

2.08×

Asset mix

Trend

Other

82.23%

Cash and investments

9.27%

Goodwill & intangibles

8.50%

Reinvestment returns

No breakdown available